Related references
Note: Only part of the references are listed.CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease
Rodrigo Liberal et al.
JOURNAL OF AUTOIMMUNITY (2016)
A molecular marker of disease activity in autoimmune liver diseases with histopathological correlation; FoXp3/RORγt ratio
Suvradeep Mitra et al.
APMIS (2015)
Paediatric Autoimmune Liver Disease
Rodrigo Liberal et al.
DIGESTIVE DISEASES (2015)
EASL Clinical Practice Guidelines: Autoimmune hepatitis
JOURNAL OF HEPATOLOGY (2015)
Update on Autoimmune Hepatitis
Rodrigo Liberal et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression
Li Zhao et al.
PLOS ONE (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis
K. Harada et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Comment on Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis in Primary Biliary Cirrhosis
Lucy J. Walker et al.
HEPATOLOGY (2009)
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Jean M. Fletcher et al.
JOURNAL OF IMMUNOLOGY (2009)
Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis
Motoko Sasaki et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years
CW Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
MS Longhi et al.
JOURNAL OF HEPATOLOGY (2004)
Share Paper
